Federal Register / Vol. 60, No. 87 / Friday, May 5, 1995 / Notices 22397

*Commissioner Scroggins did not participate in

this proceeding.

By the Commission.*

Joseph C. Polking,

Secretary.

[FR Doc. 95–10993 Filed 5–4–95; 8:45 am]

BILLING CODE 6730–01–M

FEDERAL RESERVE SYSTEM

Citizens Investment Company, Inc.;

Formation of, Acquisition by, or

Merger of Bank Holding Companies

The company listed in this notice has

applied for the Board’s approval under

section 3 of the Bank Holding Company

Act (12 U.S.C. 1842) and § 225.14 of the

Board’s Regulation Y (12 CFR 225.14) to

become a bank holding company or to

acquire a bank or bank holding

company. The factors that are

considered in acting on the applications

are set forth in section 3(c) of the Act

(12 U.S.C. 1842(c)).

The application is available for

immediate inspection at the Federal

Reserve Bank indicated. Once the

application has been accepted for

processing, it will also be available for

inspection at the offices of the Board of

Governors. Interested persons may

express their views in writing to the

Reserve Bank indicated for that

application or to the offices of the Board

of Governors. Any comment on an

application that requests a hearing must

include a statement of why a written

presentation would not suffice in lieu of

a hearing, identifying specifically any

questions of fact that are in dispute and

summarizing the evidence that would

be presented at a hearing.

Comments regarding this application

must be received not later than May 30,

1995.

A. Federal Reserve Bank of

Minneapolis (James M. Lyon, Vice

President) 250 Marquette Avenue,

Minneapolis, Minnesota 55480:

1. Citizens Investment Company, Inc.,

Glenville, Minnesota; to acquire 100

percent of the voting shares of Twin

Lakes State Bank, Twin Lakes,

Minnesota.

Board of Governors of the Federal Reserve

System, May 1, 1995.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 95–11140 Filed 5–4–95; 8:45 am]

BILLING CODE 6210–01–F

Premier Financial Bancorp, Inc.; Notice

of Application to Engage de novo in

Permissible Nonbanking Activities

The company listed in this notice has

filed an application under § 225.23(a)(1)

of the Board’s Regulation Y (12 CFR

225.23(a)(1)) for the Board’s approval

under section 4(c)(8) of the Bank

Holding Company Act (12 U.S.C.

1843(c)(8)) and § 225.21(a) of Regulation

Y (12 CFR 225.21(a)) to commence or to

engage de novo, either directly or

through a subsidiary, in a nonbanking

activity that is listed in § 225.25 of

Regulation Y as closely related to

banking and permissible for bank

holding companies. Unless otherwise

noted, such activities will be conducted

throughout the United States.

The application is available for

immediate inspection at the Federal

Reserve Bank indicated. Once the

application has been accepted for

processing, it will also be available for

inspection at the offices of the Board of

Governors. Interested persons may

express their views in writing on the

question whether consummation of the

proposal can ‘‘reasonably be expected to

produce benefits to the public, such as

greater convenience, increased

competition, or gains in efficiency, that

outweigh possible adverse effects, such

as undue concentration of resources,

decreased or unfair competition,

conflicts of interests, or unsound

banking practices.’’ Any request for a

hearing on this question must be

accompanied by a statement of the

reasons a written presentation would

not suffice in lieu of a hearing,

identifying specifically any questions of

fact that are in dispute, summarizing the

evidence that would be presented at a

hearing, and indicating how the party

commenting would be aggrieved by

approval of the proposal.

Comments regarding the application

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than May 19, 1995.

A. Federal Reserve Bank of Cleveland

(John J. Wixted, Jr., Vice President) 1455

East Sixth Street, Cleveland, Ohio

44101:

1. Premier Financial Bancorp, Inc.,

Vanceburg, Kentucky; to engage denovo

through its subsidiary, Premier Data

Services, Inc., Vanceburg, Kentucky, in

providing data processing and data

transmission services, facilities

(including data processing and data

transmission hardware, software,

documentation, and operating

personnel) and data bases to its existing

and subsidiaries and other financial

institutions, pursuant to § 225.25(b)(7)

of the Board’s Regulation Y.

Board of Governors of the Federal Reserve

System, May 1, 1995.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 95–11141 Filed 5–4–95; 8:45 am]

BILLING CODE 6210–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Announcement 534]

National Institute for Occupational

Safety and Health; Worker Exposure

Assessment and Hazard and Medical

Surveillance Programs; Notice of

Availability of Funds for Fiscal Year

1995

Introduction

The Centers for Disease Control and

Prevention (CDC), National Institute for

Occupational Safety and Health

(NIOSH) announces the availability of

fiscal year (FY) 1995 funds for a grant

program for worker hazard and medical

surveillance projects associated with

occupational exposures to radiation and

other hazardous agents at nuclear

facilities and other energy-related

industries. Studies conducted in the

nuclear power industry and deliberate

exposure of human subjects in radiation

experiments are outside the scope of

this announcement.

The Public Health Service (PHS) is

committed to achieving the health

promotion and disease prevention

objectives of ‘‘Healthy People 2000,’’ a

PHS-led national activity to reduce

morbidity and mortality and improve

the quality of life. This announcement

is related to the priority area of

Occupational Safety and Health. (For

ordering a copy of ‘‘Healthy People

2000,’’ see section ‘‘Where to Obtain

Additional Information.’’)

Authority

This program is authorized under the

Occupational Safety and Health Act of

1970, Section 20(a) and 22(e)(7), [29

U.S.C. 669(a) and 671(e)(7)]. The

applicable grant program regulations are

in 42 CFR Part 52.

Smoke-Free Workplace

PHS strongly encourages all grant

recipients to provide a smoke-free

workplace and to promote the non-use

of all tobacco products, and Public Law

103–227, the Pro-Children Act of 1994,

prohibits smoking in certain facilities

that receive Federal funds in which

education, library, day care, health care,
22398 Federal Register / Vol. 60, No. 87 / Friday, May 5, 1995 / Notices

and early childhood development

services are provided to children.

Eligible Applicants

Eligible applicants include domestic

non-profit and for-profit organizations,

universities, colleges, research

institutions, national laboratories, other

public and private organizations,

including State and local governments,

labor unions and other employee

representative groups, and small,

minority and/or women-owned

businesses.

Availability of Funds

Approximately $1.5 million is

available in FY 1995 to fund

approximately 4 to 6 research project

grants (R01). It is expected that the

average award will be $300,000, ranging

from $200,000 to $400,000 in total costs

(direct and indirect costs) per year. It is

expected that the awards will begin on

or about September 1, 1995, and will be

made for a 12-month budget period

within a project period of up to 3 years.

Continuation awards within the

project period will be made on the basis

of satisfactory progress and availability

of funds.

Purpose

The efforts funded by these grants

will help in the development of model

exposure assessment and hazard and

medical surveillance programs

applicable to both the defense nuclear

industry and general occupational

settings. NIOSH will support applied

field research projects to develop

surveillance methodologies and to

assess the functional, real-world

outcomes of model program(s).

Therefore, to assess what components

might be needed for a comprehensive

model surveillance program (applicable

to defense nuclear sites and to

occupational settings in general),

grantees may review and compare

activities at existing pilot surveillance

program sites.

Program Interests

1. Job Task Analysis/Exposure

Assessment and Hazard Surveillance

Workers should be classified

according to risk in medical and

epidemiological surveillance programs.

An understanding of prospective and

retrospective exposures is required to

properly classify workers into risk

groups. Frequently, the absence of

exposure monitoring data on individual

workers results in a reliance on

surrogate measures of exposure, such as

job titles, to estimate risks for groups of

workers. Even where exposure

monitoring data may be abundant, its

interpretation may result in poor

estimates of worker risk if the purpose

for collecting the data is vague or

unknown. Analyses of job titles,

building occupancy, and operational

procedures and practices have been

linked with exposure monitoring data to

improve classification methods. The

ideal approach for exposure monitoring

and other subjective assessment

techniques, in support of medical and

epidemiologic surveillance programs,

has been shown to require accurate

characterization of exposures associated

with specific job tasks which may then

be weighted appropriately for

individual workers performing different

series of tasks. The outcome from such

a strategy is that more valid estimates of

exposure are available on groups of

workers, resulting in more reliable

estimates of risk. However, the

disadvantages of such an approach are

that it is resource intensive and limited

primarily to prospective studies.

Therefore, there is a need for research to

improve and further develop feasible

strategies to assess and record

occupational exposures to potentially

harmful hazards.

a. Worker self-monitoring. Proposals

are solicited to look at existing

programs, evaluate these existing

programs and develop new methods (as

appropriate) that could be used to

demonstrate reliable worker selfmonitoring and subjective exposure

assessment techniques. A proposal that

identifies the sources of errors when

workers self monitor and suggests

methods that would minimize those

errors would be responsive to this

request. The success of ‘‘selfmonitoring’’ should be analyzed in

contrast to classical industrial hygiene/

health physics directed monitoring.

b. Biological exposure indicators. In

many situations biological exposure

indicators are useful measures of an

individual’s exposure. Proposals are

solicited to look at existing programs, to

evaluate these existing programs and to

develop new non-invasive biological

exposure indicators (Reference—1994–

1995 Threshold Limit Values and

Biological Exposure Indices, American

Conference of Governmental Industrial

Hygienists, 1994.)

c. Exposure histories. Exposure

history questionnaires depend on the

individual’s ability to remember details

of tasks performed and materials used in

past work assignments. More accurate

information might be possible if the

questionnaires could be better linked to

data about hazards and hazardous

material and agents used in the

facilities. Proposals are solicited to look

at existing programs, to evaluate these

existing programs and to develop, as

appropriate, methods that would aid an

individual in more accurately

reconstructing exposures to health and

injury hazards.

d. Other proposals. Proposals are

sought to look at existing programs, to

evaluate these existing programs and to

develop appropriate innovative methods

to accurately group employees by

exposure so that medical and

epidemiologic surveillance programs

can be better targeted at occupational

health and injury outcomes.

2. Medical Screening

To ensure the highest quality, state-ofthe-art occupational health care for

workers, it is essential that medical

screening examinations be directed

toward the detection and treatment of

health effects and/or adverse health

outcomes from a multitude of exposures

in the workplace. For example, at

nuclear energy facilities important

work-related diseases and injuries

include such problems as bladder

cancer, beryllium disease, hearing loss,

musculoskeletal injuries, heat stress,

and radiation effects. Similar diseases

and injuries are important to nondefense nuclear facilities having work

activities related to hazardous waste

operations or where similar exposures

might occur.

With this in mind, a ‘‘convincing’’

decision logic needs to be developed for

what should trigger specific medical

screening (and the medical surveillance

program components thereof). This

decision logic needs to be generic in

nature and be developed for the types of

potential exposures/diseases such as

those of hazardous waste workers and

workers conducting decontamination

and decommissioning operations.

Proposals should demonstrate the

familiarity with medical screening,

public health surveillance and the

general principles of conducting such

activities.

Research also needs to be conducted

for:

(a) Assessment of existing clinical

screening tests and biomarkers related

to radiation and non-radiation

exposures; and

(b) Development of new clinical

screening tests and biomarkers related

to selected radiation and non-radiation

exposures.

Grant proposals can be submitted as

a response to Items 1. and/or 2. as

presented above. Within Item 1.,

proposals can be submitted for one or

more of a.-d. In addition, for each

project chosen, the proposals should

include a component on evaluating the

economic benefits of implementing an
Federal Register / Vol. 60, No. 87 / Friday, May 5, 1995 / Notices 22399

improved surveillance program in the

selected surveillance area ( i.e., the cost

benefits of reducing and/or eliminating

workplace hazards versus keeping a

situation ‘‘status quo’’).

Inclusion of Minorities and Women in

Study Populations

Applicants are required to give added

attention (where feasible and

appropriate) to the inclusion of

minorities and/or women study

populations for research into the

etiology of diseases, research in

behavioral and social sciences, clinical

studies of treatment and treatment

outcomes, research on the dynamics of

health care and its impact on disease,

and appropriate interventions for

disease prevention and health

promotion. Exceptions would be studies

of diseases which exclusively affect

males or where involvement of pregnant

women may expose the fetus to undue

risks. If minorities and/or women are

not included in a given study, a clear

rationale for their exclusion must be

provided.

Evaluation Criteria

1. General

Upon receipt, applications will be

reviewed for completeness and

responsiveness by NIOSH, CDC.

Incomplete applications will be

returned to the applicant without

further consideration. If NIOSH, CDC

staff find that the application is not

responsive to the Request for Assistance

(RFA), it will be returned without further

consideration.

The conduct of the research will

require that the successful applicant

develop and maintain a working

relationship with the management and

employee representatives at the site(s)

selected for study. Letters of support

and/or cooperation are needed in the

grant application. For more information

about these letters, potential applicants

should contact the programmatic

technical advisor (Dr. Roy Fleming)

listed in the subsequent section ‘‘Where

to Obtain Additional Information.’’

2. Peer Review

Applications that are complete and

responsive to the RFA will be evaluated

for scientific and technical merit by an

appropriate peer review group convened

by the NIOSH, CDC, in accordance with

the review criteria stated below. As part

of the initial peer review, a process

(triage) may be used by the initial

review group in which applications will

be determined to be competitive or noncompetitive based on their scientific

merit relative to other applications

received in response to the RFA.

Applications judged to be competitive

will be discussed and assigned a

priority score. Applications determined

to be non-competitive will be

withdrawn from further consideration;

the Principal Investigator/Program

Director and the official signing for the

applicant organization will be promptly

notified.

Review Criteria

a. Scientific, technical, or medical

significance and originality of proposed

research;

b. Appropriateness and adequacy of

the experimental approach and

methodology proposed to carry out the

research;

c. Qualifications and research

experience of the Principal Investigator

and staff, particularly, but not

exclusively, in the area of the proposed

research;

d. Availability of resources necessary

to perform the research; and

e. Adequacy of plans to include both

genders and minorities and their

subgroups, as appropriate, for the

scientific goals of the research. (Plans

for the recruitment and retention of

subjects will also be evaluated.)

The peer review group also will

critically examine the submitted budget

and recommend an appropriate budget

and period of support for each scored

application.

3. Secondary Review

In the secondary (programmatic

importance) review, the following

factors will be considered:

a. Results of the initial peer review;

b. Magnitude of the problem in terms

of numbers of workers affected;

c. Severity of the disease or injury in

the worker population; and

d. Usefulness to applied technical

knowledge in the identification,

evaluation, and/or control of

occupational safety and health hazards.

4. Funding Decisions

Applicants will compete for available

funds with all other approved

applications. The following will be

considered in making funding

decisions:

a. Quality of the proposed project as

determined by peer review;

b. Availability of funds; and

c. Program balance among research

areas described in the announcement.

Executive Order 12372 Review

This program is not subject to the

Executive Order 12372 review.

Public Health System Reporting

Requirement

This program is not subject to the

Public Health System Reporting

Requirements.

Catalog of Federal Domestic Assistance

Number

The Catalog of Federal Domestic

Assistance number is 93.262.

Other Requirements

Human Subjects

If the proposed project involves

research on human subjects, the

applicant must comply with the

Department of Health and Human

Services Regulations, 45 CFR Part 46,

regarding the protection of human

subjects. Assurance must be provided to

demonstrate that the project will be

subject to initial and continuing review

by the appropriate institutional review

committees. The applicant will be

responsible for providing assurance in

accordance with the appropriate

guidelines and form provided in the

application kit.

Application Submission and Deadlines

1. Preapplication Letter of Intent

Although not a prerequisite of

application, a non-binding letter of

intent-to-apply is requested from

potential applicants. The letter should

be submitted to the Grants Management

Branch, CDC (see ‘‘Applications’’ for

address). It should be postmarked no

later than June 5, 1995. The letter

should identify the announcement

number, name of Principal Investigator,

and specify the priority area to be

addressed by the proposed project. The

letter of intent does not influence

review or funding decisions, but it will

enable NIOSH/CDC to plan the review

more efficiently, and will ensure that

each applicant receives timely and

relevant information prior to application

submission.

2. Applications

Applicants should use Form PHS–398

(OMB Number 0925–0001) and adhere

to the ERRATA Instruction Sheet for

Form PHS–398 contained in the

application package. The original and

five copies of the application must be

submitted to Henry S. Cassell, III, Grants

Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention, (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E13, Atlanta, GA 30305 on or

before July 3, 1995.
22400 Federal Register / Vol. 60, No. 87 / Friday, May 5, 1995 / Notices

3. Deadline

A. Applications shall be considered as

meeting the deadline if they are either:

1. Received at the above address on or

before the deadline date; or

2. Sent on or before the deadline date

to the above address, and received in

time for the review process. (Applicants

must request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

of the U.S. Postal Service. Private

metered postmarks shall not be accepted

as proof of timely mailing.)

B. Applications which do not meet

the criteria in 3.A.1. or 3.A.2. above are

considered late applications. Late

applications will not be considered in

the current competition and will be

returned to the applicant.

Where to Obtain Additional

Information

To receive additional written

information call (404) 332–4561. You

will be asked to leave your name,

address and telephone number and will

need to refer to Announcement 534.

You will receive a complete program

description, information on application

procedures, and application forms.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from Georgia

L. Jang, Grants Management Specialist,

Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Room 300, Mailstop E13, Atlanta, GA

30305, telephone (404) 842–6796.

Programmatic technical assistance may

be obtained from Roy M. Fleming, Sc.D.,

Associate Director for Grants, National

Institute for Occupational Safety and

Health, Centers for Disease Control and

Prevention (CDC), 1600 Clifton Road,

NE., Building 1, Room 3053, Mail Stop

D–30, Atlanta, GA 30333, telephone

(404) 639–3343.

Please refer to Announcement 534

when requesting information and

submitting an application.

Potential applicants may obtain a

copy of ‘‘Healthy People 2000’’ (Full

Report, Stock No. 017–001–00474–0) or

‘‘Healthy People 2000’’ (Summary

Report, Stock No. 017–001–00473–1)

through the Superintendent of

Documents, Government Printing

Office, Washington, DC 20402–9325,

telephone (202) 512–1800.

Dated: May 1, 1995.

Linda Rosenstock,

Director, National Institute for Occupational

Safety and Health, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 95–11139 Filed 5–4–95; 8:45 am]

BILLING CODE 4163–19–P

Food and Drug Administration

[Docket No. 95F–0092]

Amoco Corp.; Filing of Food Additive

Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Amoco Corp. has filed a petition

proposing that the food additive

regulations be amended to provide for

the safe use of ethylene terephthalateisophthalate copolymers prepared such

that the finished copolymers contain 83

to 97 weight percent of polymer units

derived from ethylene terephthalate as

articles or components of articles in

contact with food.

DATES: Written comments on the

petitioner’s environmental assessment

by June 5, 1995.

ADDRESSES: Submit written comments

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, rm. 1–23, 12420

Parklawn Dr., Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT:

Richard H. White, Center for Food

Safety and Applied Nutrition (HFS–

216), Food and Drug Administration,

200 C St. SW., Washington, DC 20204,

202–418–3094.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a food additive

petition (FAP 5B4455) has been filed by

Amoco Corp., 200 East Randolph Dr.,

Chicago, IL 60601–7125. The petition

proposes to amend the food additive

regulations in § 177.1630 Polyethylene

phthalate polymers (21 CFR 177.1630)

to provide for the safe use of ethylene

terephthalate-isophthalate copolymers

prepared such that the finished

copolymers contain 83 to 97 weight

percent of polymer units derived from

ethylene terephthalate, as articles or

components of articles in contact with

food.

The potential environmental impact

of this action is being reviewed. To

encourage public participation

consistent with regulations promulgated

under the National Environmental

Policy Act (40 CFR 1501.4(b)), the

agency is placing the environmental

assessment submitted with the petition

that is the subject of this notice on

public display at the Dockets

Management Branch (address above) for

public review and comment. Interested

persons may, on or before June 5, 1995,

submit to the Dockets Management

Branch (address above) written

comments. Two copies of any comments

are to be submitted, except that

individuals may submit one copy.

Comments are to be identified with the

docket number found in brackets in the

heading of this document. Received

comments may be seen in the office

above between 9 a.m. and 4 p.m.,

Monday through Friday. FDA will also

place on public display any

amendments to, or comments on, the

petitioner’s environmental assessment

without further announcement in the

Federal Register. If, based on its review,

the agency finds that an environmental

impact statement is not required and

this petition results in a regulation, the

notice of availability of the agency’s

finding of no significant impact and the

evidence supporting that finding will be

published with the regulation in the

Federal Register in accordance with 21

CFR 25.40(c).

Dated: April 25, 1995.

Alan M. Rulis,

Acting Director, Office of Premarket

Approval, Center for Food Safety and Applied

Nutrition.

[FR Doc. 95–11061 Filed 5–4–95; 8:45 am]

BILLING CODE 4160–01–F

[Docket No. 93N–0156]

Report on Nutrition Labeling

Information Study; Raw Fruits,

Vegetables, and Fish; Availability

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing the

availability of a report entitled ‘‘Food

and Drug Administration Nutrition

Labeling Information Study, Raw Fruits/

Vegetables and Raw Fish.’’ This report

is intended to summarize survey data on

actions taken by food retailers to

provide consumers with nutrition

labeling information for raw fruits,

vegetables, and fish. This report is

mandated by the Nutrition Labeling and

Education Act of 1990 (the 1990

amendments).

DATES: Comments may be submitted at

any time.